Objectives: This dose-ranging study evaluated the antihypertensive efficacy and tolerability of aliskiren in patients with mild-to-moderate hypertension.
目的：本研究是评估阿利克伦在轻中度高血压患者中的有效及耐受剂量范围。
2
There was no relation between the cumulative dose of cabergoline and the presence of mild, moderate, or severe valve regurgitation.
卡麦角林的累积剂量和轻度、中度、重度瓣膜返流无明显相关。
3
At the proposed starting dose of 5 grams, the drug was found to be generally well tolerated with side effects that were mild to moderate.